MAPK3 and breast cancer: Resistant BC cells secrete exosomes enriched for the EPH receptor A2 (EphA2) protein, which translocates as a receptor to chemotherapy‐sensitive BC cells and binds Ephrin A1 ligand, thereby activating the downstream ERK1/2 signaling pathway and inducing chemotherapy resistance.113